Love Pharma Inc (TSE:JOLT) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Jolt Health Inc. has canceled its arrangement to acquire a transdermal drug delivery technology and is redirecting its efforts to the artificial intelligence sector, aiming to drive innovation in healthcare. The company’s CEO expressed confidence in AI to strengthen their health and wellness offerings and is optimistic about recent interest rate cuts boosting the economy. Jolt Health maintains exclusive licenses for various therapeutic and pharmaceutical products across Europe, the UK, and North America.
For further insights into TSE:JOLT stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue